India · Delayed Price · Currency is INR NSE:SUNPHARMA Statistics
Total Valuation
NSE:SUNPHARMA has a market cap or net worth of INR 4.43 trillion. The enterprise value is 4.15 trillion.
| Market Cap | 4.43T |
| Enterprise Value | 4.15T |
Important Dates
The last earnings date was Friday, May 22, 2026.
| Earnings Date | May 22, 2026 |
| Ex-Dividend Date | Feb 5, 2026 |
Share Statistics
NSE:SUNPHARMA has 2.40 billion shares outstanding. The number of shares has increased by 0.09% in one year.
| Current Share Class | 2.40B |
| Shares Outstanding | 2.40B |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | 12.01% |
| Owned by Institutions (%) | 30.26% |
| Float | 1.06B |
Valuation Ratios
The trailing PE ratio is 38.59 and the forward PE ratio is 32.63. NSE:SUNPHARMA's PEG ratio is 2.31.
| PE Ratio | 38.59 |
| Forward PE | 32.63 |
| PS Ratio | 7.57 |
| PB Ratio | 5.28 |
| P/TBV Ratio | 7.35 |
| P/FCF Ratio | 50.24 |
| P/OCF Ratio | 35.64 |
| PEG Ratio | 2.31 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.25, with an EV/FCF ratio of 47.10.
| EV / Earnings | 36.15 |
| EV / Sales | 7.10 |
| EV / EBITDA | 25.25 |
| EV / EBIT | 30.75 |
| EV / FCF | 47.10 |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.82 |
| Quick Ratio | 2.12 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | 0.53 |
| Interest Coverage | 39.99 |
Financial Efficiency
Return on equity (ROE) is 14.72% and return on invested capital (ROIC) is 18.59%.
| Return on Equity (ROE) | 14.72% |
| Return on Assets (ROA) | 8.43% |
| Return on Invested Capital (ROIC) | 18.59% |
| Return on Capital Employed (ROCE) | 15.73% |
| Weighted Average Cost of Capital (WACC) | 4.79% |
| Revenue Per Employee | 13.60M |
| Profits Per Employee | 2.67M |
| Employee Count | 43,000 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 1.04 |
Taxes
In the past 12 months, NSE:SUNPHARMA has paid 35.54 billion in taxes.
| Income Tax | 35.54B |
| Effective Tax Rate | 23.60% |
Stock Price Statistics
The stock price has increased by +6.25% in the last 52 weeks. The beta is 0.10, so NSE:SUNPHARMA's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | +6.25% |
| 50-Day Moving Average | 1,773.69 |
| 200-Day Moving Average | 1,711.40 |
| Relative Strength Index (RSI) | 54.75 |
| Average Volume (20 Days) | 5,425,035 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SUNPHARMA had revenue of INR 584.62 billion and earned 114.79 billion in profits. Earnings per share was 47.80.
| Revenue | 584.62B |
| Gross Profit | 469.18B |
| Operating Income | 135.53B |
| Pretax Income | 150.63B |
| Net Income | 114.79B |
| EBITDA | 164.91B |
| EBIT | 135.53B |
| Earnings Per Share (EPS) | 47.80 |
Balance Sheet
The company has 325.37 billion in cash and 46.27 billion in debt, with a net cash position of 279.09 billion or 116.32 per share.
| Cash & Cash Equivalents | 325.37B |
| Total Debt | 46.27B |
| Net Cash | 279.09B |
| Net Cash Per Share | 116.32 |
| Equity (Book Value) | 838.80B |
| Book Value Per Share | 347.95 |
| Working Capital | 412.69B |
Cash Flow
In the last 12 months, operating cash flow was 124.19 billion and capital expenditures -36.09 billion, giving a free cash flow of 88.10 billion.
| Operating Cash Flow | 124.19B |
| Capital Expenditures | -36.09B |
| Depreciation & Amortization | 29.38B |
| Net Borrowing | 17.61B |
| Free Cash Flow | 88.10B |
| FCF Per Share | 36.72 |
Margins
Gross margin is 80.25%, with operating and profit margins of 23.18% and 19.64%.
| Gross Margin | 80.25% |
| Operating Margin | 23.18% |
| Pretax Margin | 25.77% |
| Profit Margin | 19.64% |
| EBITDA Margin | 28.21% |
| EBIT Margin | 23.18% |
| FCF Margin | 15.07% |
Dividends & Yields
This stock pays an annual dividend of 16.00, which amounts to a dividend yield of 0.87%.
| Dividend Per Share | 16.00 |
| Dividend Yield | 0.87% |
| Dividend Growth (YoY) | 6.45% |
| Years of Dividend Growth | 7 |
| Payout Ratio | 34.27% |
| Buyback Yield | -0.09% |
| Shareholder Yield | 0.78% |
| Earnings Yield | 2.59% |
| FCF Yield | 1.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 29, 2013. It was a forward split with a ratio of 2.
| Last Split Date | Jul 29, 2013 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |